5. Literaturverzeichnis gesamt

[1] Suriawinata, A. A. und Thung, S. N. (2002): Malignant liver tumors, Clin Liver Dis (6) [2], Seite 527-54, ix. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12122869

[2] Renshaw, K (1922): Malignant neoplasms of extahepatic biliary ducts., Ann. Surg. (76), Seite 205-221.

[3] Klatskin, G. (1965): Adenocarcinoma of the Hepatic Duct at Its Bifurcation within the Porta Hepatis. An Unusual Tumor with Distinctive Clinical and Pathological Features, Am J Med (38), Seite 241-56. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14256720

[4] Beckurts, K. T.; Holscher, A. H.; Bauer, T. H. und Siewert, J. R. (1997): [Malignant tumors of the hepatic bifurcation--results of surgical therapy and prognostic factors], Chirurg (68) [4], Seite 378-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9206632

[5] Bismuth, H. (1982): Surgical anatomy and anatomical surgery of the liver, World J Surg (6) [1], Seite 3-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7090393

[6] Jonas, S.; Bechstein, W. O.; Kling, N. und Neuhaus, P. (1997): [Extent of resection in surgical therapy of central bile duct carcinomas], Langenbecks Arch Chir Suppl Kongressbd (114), Seite 1075-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9574337

[7] Neuhaus, P. und Blumhardt, G. (1994): Extended bile duct resection--a new oncological approach to the treatment of central bile duct carcinomas? Description of method and early results, Langenbecks Arch Chir (379) [2], Seite 123-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8196428

[8] Sobin, LH und Wittekind, C. (2002): UICC: TNM classification of malignant tumors 6th edn., Wiley-Liss, New York.

[9] Tannapfel, A. und Wittekind, C. (2001): [Anatomy and pathology of intrahepatic and extrahepatic bile duct tumors], Pathologe (22) [2], Seite 114-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11321727

[10] Colombari, R. und Tsui, W. M. (1995): Biliary tumors of the liver, Semin Liver Dis (15) [4], Seite 402-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8578323

[11] Tannapfel, A. und Wittekind, C. (2004): Gallenblasen- und Gallengangskarzinom. Biologie und Pathologie., Internist (Berl) (45) [1], Seite 33-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14735242

[12] Caca, K.; Feisthammel, J.; Klee, K.; Tannapfel, A.; Witzigmann, H.; Wittekind, C.; Mossner, J. und Berr, F. (2002): Inactivation of the INK4a/ARF locus and p53 in sporadic extrahepatic bile duct cancers and bile tract cancer cell lines, Int J Cancer (97) [4], Seite 481-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11802210

[13] Davis, R. I.; Sloan, J. M.; Hood, J. M. und Maxwell, P. (1988): Carcinoma of the extrahepatic biliary tract: a clinicopathological and immunohistochemical study, Histopathology (12) [6], Seite 623-31. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3417244

[14] Jarnagin, W. R. (2000): Cholangiocarcinoma of the extrahepatic bile ducts, Semin Surg Oncol (19) [2], Seite 156-76. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11126380

[15] Harder, J. und Blum, H. E. (2002): [Cholangiocarcinoma], Schweiz Rundsch Med Prax (91) [34], Seite 1352-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12233266

[16] Nagorney, D. M.; Donohue, J. H.; Farnell, M. B.; Schleck, C. D. und Ilstrup, D. M. (1993): Outcomes after curative resections of cholangiocarcinoma, Arch Surg (128) [8], Seite 871-7; discussion 877-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8393652

[17] Nakeeb, A.; Pitt, H. A.; Sohn, T. A.; Coleman, J.; Abrams, R. A.; Piantadosi, S.; Hruban, R. H.; Lillemoe, K. D.; Yeo, C. J. und Cameron, J. L. (1996): Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors, Ann Surg (224) [4], Seite 463-73; discussion 473-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8857851

[18] Chijiiwa, K.; Ohtani, K.; Noshiro, H.; Yamasaki, T.; Shimizu, S.; Yamaguchi, K. und Tanaka, M. (2002): Cholangiocellular carcinoma depending on the kind of intrahepatic calculi in patients with hepatolithiasis, Hepatogastroenterology (49) [43], Seite 96-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11941992

[19] Falchuk, K. R.; Lesser, P. B.; Galdabini, J. J. und Isselbacher, K. J. (1976): Cholangiocarcinoma as related to chronic intrahepatic cholangitis and hepatolithiasis. Case report and review of the literature, Am J Gastroenterol (66) [1], Seite 57-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=184709

[20] Kim, Y. T.; Byun, J. S.; Kim, J.; Jang, Y. H.; Lee, W. J.; Ryu, J. K.; Kim, S. W.; Yoon, Y. B. und Kim, C. Y. (2003): Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis, Hepatogastroenterology (50) [49], Seite 8-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12629979

[21] Shoda, J.; Tanaka, N. und Osuga, T. (2003): Hepatolithiasis--epidemiology and pathogenesis update, Front Biosci (8), Seite e398-409. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12700089

[22] Wiesner, R. H.; Porayko, M. K.; Hay, J. E.; LaRusso, N. F.; Steers, J. L.; Krom, R. A. und Dickson, E. R. (1996): Liver transplantation for primary sclerosing cholangitis: impact of risk factors on outcome, Liver Transpl Surg (2) [5 Suppl 1], Seite 99-108. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9346709

[23] Broome, U.; Olsson, R.; Loof, L.; Bodemar, G.; Hultcrantz, R.; Danielsson, A.; Prytz, H.; Sandberg-Gertzen, H.; Wallerstedt, S. und Lindberg, G. (1996): Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis, Gut (38) [4], Seite 610-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8707097

[24] Verbeek, P. C.; van Leeuwen, D. J.; de Wit, L. T.; Reeders, J. W.; Smits, N. J.; Bosma, A.; Huibregtse, K. und van der Heyde, M. N. (1992): Benign fibrosing disease at the hepatic confluence mimicking Klatskin tumors, Surgery (112) [5], Seite 866-71. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1332203

[25] Knollmann, F. D.; Adler, A.; Maurer, J.; Grunewald, T.; Hintze, R. E.; Schedel, H. und Veltzke, W. (1995): [Comparative imaging of HIV associated diseases of the hepatobiliary system in computerized tomography and cholangiography], Aktuelle Radiol (5) [4], Seite 216-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7548245

[26] Sanchez-Urdazpal, L.; Gores, G. J.; Ward, E. M.; Maus, T. P.; Buckel, E. G.; Steers, J. L.; Wiesner, R. H. und Krom, R. A. (1993): Diagnostic features and clinical outcome of ischemic-type biliary complications after liver transplantation, Hepatology (17) [4], Seite 605-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8477965

[27] May, G. R.; Bender, C. E.; LaRusso, N. F. und Wiesner, R. H. (1985): Nonoperative dilatation of dominant strictures in primary sclerosing cholangitis, AJR Am J Roentgenol (145) [5], Seite 1061-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3876737

[28] Beuers, U.; Spengler, U.; Kruis, W.; Aydemir, U.; Wiebecke, B.; Heldwein, W.; Weinzierl, M.; Pape, G. R.; Sauerbruch, T. und Paumgartner, G. (1992): Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial, Hepatology (16) [3], Seite 707-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1505913

[29] Stiehl, A.; Walker, S.; Stiehl, L.; Rudolph, G.; Hofmann, W. J. und Theilmann, L. (1994): Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period, J Hepatol (20) [1], Seite 57-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8201224

[30] Johnson, G. K.; Geenen, J. E.; Venu, R. P.; Schmalz, M. J. und Hogan, W. J. (1991): Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment, Gastrointest Endosc (37) [1], Seite 38-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2004682

[31] LaRusso, N. F.; Wiesner, R. H.; Ludwig, J. und MacCarty, R. L. (1984): Current concepts. Primary sclerosing cholangitis, N Engl J Med (310) [14], Seite 899-903. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6366557

[32] Ismail, T.; Angrisani, L.; Powell, J. E.; Hubscher, S.; Buckels, J.; Neuberger, J.; Elias, E. und McMaster, P. (1991): Primary sclerosing cholangitis: surgical options, prognostic variables and outcome, Br J Surg (78) [5], Seite 564-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2059807

[33] Mueller, P. R.; vanSonnenberg, E.; Ferrucci, J. T., Jr.; Weyman, P. J.; Butch, R. J.; Malt, R. A. und Burhenne, H. J. (1986): Biliary stricture dilatation: multicenter review of clinical management in 73 patients, Radiology (160) [1], Seite 17-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3715030

[34] Skolkin, M. D.; Alspaugh, J. P.; Casarella, W. J.; Chuang, V. P. und Galambos, J. T. (1989): Sclerosing cholangitis: palliation with percutaneous cholangioplasty, Radiology (170) [1 Pt 1], Seite 199-206. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2462261

[35] Cotton, P. B. und Nickl, N. (1991): Endoscopic and radiologic approaches to therapy in primary sclerosing cholangitis, Semin Liver Dis (11) [1], Seite 40-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2047888

[36] Grijm, R.; Huibregtse, K.; Bartelsman, J.; Mathus-Vliegen, E. M.; Dekker, W. und Tytgat, G. N. (1986): Therapeutic investigations in primary sclerosing cholangitis, Dig Dis Sci (31) [8], Seite 792-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3731972

[37] Gaing, A. A.; Geders, J. M.; Cohen, S. A. und Siegel, J. H. (1993): Endoscopic management of primary sclerosing cholangitis: review, and report of an open series, Am J Gastroenterol (88) [12], Seite 2000-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8249963

[38] Lee, J. G.; Schutz, S. M.; England, R. E.; Leung, J. W. und Cotton, P. B. (1995): Endoscopic therapy of sclerosing cholangitis, Hepatology (21) [3], Seite 661-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7875664

[39] Ponsioen, C. Y.; Lam, K.; van Milligen de Wit, A. W.; Huibregtse, K. und Tytgat, G. N. (1999): Four years experience with short term stenting in primary sclerosing cholangitis, Am J Gastroenterol (94) [9], Seite 2403-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10483999

[40] van Milligen de Wit, A. W.; van Bracht, J.; Rauws, E. A.; Jones, E. A.; Tytgat, G. N. und Huibregtse, K. (1996): Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis, Gastrointest Endosc (44) [3], Seite 293-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8885349

[41] Wagner, S.; Gebel, M.; Meier, P.; Trautwein, C.; Bleck, J.; Nashan, B. und Manns, M. P. (1996): Endoscopic management of biliary tract strictures in primary sclerosing cholangitis, Endoscopy (28) [7], Seite 546-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8911801

[42] Wiesner, R. H. (2001): Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease, Best Pract Res Clin Gastroenterol (15) [4], Seite 667-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11492975

[43] Hintze, R.E.; Abou-Rebyeh, H.; Veltzke-Schlieker, W.; Adler, A und Wiedenmann, B. (2001): Endoskopische Therapiemöglichkeiten der PSC., Dignass, A. und Stein, J., Chronisch entzündliche Darmerkrankungen, Seite 161-170, Springer, Berlin.

[44] Siqueira, E.; Schoen, R. E.; Silverman, W.; Martin, J.; Rabinovitz, M.; Weissfeld, J. L.; Abu-Elmaagd, K.; Madariaga, J. R.; Slivka, A. und Martini, J. (2002): Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis, Gastrointest Endosc (56) [1], Seite 40-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12085033

[45] Patel, A. H.; Harnois, D. M.; Klee, G. G.; LaRusso, N. F. und Gores, G. J. (2000): The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis, Am J Gastroenterol (95) [1], Seite 204-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10638584

[46] Wetter, L. A.; Ring, E. J.; Pellegrini, C. A. und Way, L. W. (1991): Differential diagnosis of sclerosing cholangiocarcinomas of the common hepatic duct (Klatskin tumors), Am J Surg (161) [1], Seite 57-62; discussion 62-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1846276

[47] Singh, V.; Bhasin, S.; Nain, C. K.; Gupta, S. K.; Singh, G. und Bose, S. M. (2003): Brush cytology in malignant biliary obstruction, Indian J Pathol Microbiol (46) [2], Seite 197-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15022908

[48] Kim, H. J.; Kim, M. H.; Lee, S. K.; Yoo, K. S.; Seo, D. W. und Min, Y. I. (2000): Tumor vessel: a valuable cholangioscopic clue of malignant biliary stricture, Gastrointest Endosc (52) [5], Seite 635-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11060188

[49] Bloom, C. M.; Langer, B. und Wilson, S. R. (1999): Role of US in the detection, characterization, and staging of cholangiocarcinoma, Radiographics (19) [5], Seite 1199-218. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10489176

[50] Hann, L. E.; Greatrex, K. V.; Bach, A. M.; Fong, Y. und Blumgart, L. H. (1997): Cholangiocarcinoma at the hepatic hilus: sonographic findings, AJR Am J Roentgenol (168) [4], Seite 985-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9124155

[51] Hann, L. E.; Getrajdman, G. I.; Brown, K. T.; Bach, A. M.; Teitcher, J. B.; Fong, Y. und Blumgart, L. H. (1996): Hepatic lobar atrophy: association with ipsilateral portal vein obstruction, AJR Am J Roentgenol (167) [4], Seite 1017-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8819404

[52] Valls, C.; Guma, A.; Puig, I.; Sanchez, A.; Andia, E.; Serrano, T. und Figueras, J. (2000): Intrahepatic peripheral cholangiocarcinoma: CT evaluation, Abdom Imaging (25) [5], Seite 490-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10931983

[53] Tillich, M.; Mischinger, H. J.; Preisegger, K. H.; Rabl, H. und Szolar, D. H. (1998): Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma, AJR Am J Roentgenol (171) [3], Seite 651-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9725291

[54] Dooms, G. C.; Kerlan, R. K., Jr.; Hricak, H.; Wall, S. D. und Margulis, A. R. (1986): Cholangiocarcinoma: imaging by MR, Radiology (159) [1], Seite 89-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3006122

[55] Motohara, T.; Semelka, R. C. und Bader, T. R. (2003): MR cholangiopancreatography, Radiol Clin North Am (41) [1], Seite 89-96. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12630687

[56] Courbiere, M.; Pilleul, F.; Henry, L.; Ponchon, T.; Touzet, S. und Valette, P. J. (2003): Value of magnetic resonance cholangiography in benign and malignant biliary stenosis: comparative study with direct cholangiography, J Comput Assist Tomogr (27) [3], Seite 315-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12794592

[57] Adamek, H. E.; Albert, J.; Weitz, M.; Breer, H.; Schilling, D. und Riemann, J. F. (1998): A prospective evaluation of magnetic resonance cholangiopancreatography in patients with suspected bile duct obstruction, Gut (43) [5], Seite 680-3. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9824351

[58] Yeh, T. S.; Jan, Y. Y.; Tseng, J. H.; Chiu, C. T.; Chen, T. C.; Hwang, T. L. und Chen, M. F. (2000): Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings, Am J Gastroenterol (95) [2], Seite 432-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10685746

[59] Hintze, R. E.; Abou-Rebyeh, H.; Adler, A.; Veltzke-Schlieker, W.; Felix, R. und Wiedenmann, B. (2001): Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors, Gastrointest Endosc (53) [1], Seite 40-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11154487

[60] Rosch, T.; Meining, A.; Fruhmorgen, S.; Zillinger, C.; Schusdziarra, V.; Hellerhoff, K.; Classen, M. und Helmberger, H. (2002): A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures, Gastrointest Endosc (55) [7], Seite 870-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12024143

[61] Tamada, K.; Tomiyama, T.; Ichiyama, M.; Oohashi, A.; Wada, S.; Nishizono, T.; Tano, S.; Aizawa, T.; Ido, K. und Kimura, K. (1998): Influence of biliary drainage catheter on bile duct wall thickness as measured by intraductal ultrasonography, Gastrointest Endosc (47) [1], Seite 28-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9468420

[62] Tamada, K.; Tomiyama, T.; Oohashi, A.; Aizawa, T.; Nishizono, T.; Wada, S.; Tano, S.; Miyata, T.; Satoh, Y.; Ido, K. und Kimura, K. (1999): Bile duct wall thickness measured by intraductal US in patients who have not undergone previous biliary drainage, Gastrointest Endosc (49) [2], Seite 199-203. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9925698

[63] Vazquez-Sequeiros, E.; Baron, T. H.; Clain, J. E.; Gostout, C. J.; Norton, I. D.; Petersen, B. T.; Levy, M. J.; Jondal, M. L. und Wiersema, M. J. (2002): Evaluation of indeterminate bile duct strictures by intraductal US, Gastrointest Endosc (56) [3], Seite 372-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12196775

[64] Tamada, K.; Ueno, N.; Tomiyama, T.; Oohashi, A.; Wada, S.; Nishizono, T.; Tano, S.; Aizawa, T.; Ido, K. und Kimura, K. (1998): Characterization of biliary strictures using intraductal ultrasonography: comparison with percutaneous cholangioscopic biopsy, Gastrointest Endosc (47) [5], Seite 341-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9609424

[65] Domagk, D.; Poremba, C.; Dietl, K. H.; Senninger, N.; Heinecke, A.; Domschke, W. und Menzel, J. (2002): Endoscopic transpapillary biopsies and intraductal ultrasonography in the diagnostics of bile duct strictures: a prospective study, Gut (51) [2], Seite 240-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12117887

[66] Tamada, K.; Ido, K.; Ueno, N.; Ichiyama, M.; Tomiyama, T.; Nishizono, T.; Wada, S.; Noda, T.; Tano, S.; Aizawa, T. und et al. (1995): Assessment of hepatic artery invasion by bile duct cancer using intraductal ultrasonography, Endoscopy (27) [8], Seite 579-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8608750

[67] Tamada, K.; Ido, K.; Ueno, N.; Ichiyama, M.; Tomiyama, T.; Nishizono, T.; Wada, S.; Noda, T.; Tano, S.; Aizawa, T. und et al. (1995): Assessment of portal vein invasion by bile duct cancer using intraductal ultrasonography, Endoscopy (27) [8], Seite 573-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8608749

[68] Tamada, K.; Ueno, N.; Ichiyama, M.; Tomiyama, T.; Nishizono, T.; Wada, S.; Oohashi, A.; Tano, S.; Aizawa, T.; Ido, K. und Kimura, K. (1996): Assessment of pancreatic parenchymal invasion by bile duct cancer using intraductal ultrasonography, Endoscopy (28) [6], Seite 492-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8886635

[69] Tamada, K.; Nagai, H.; Yasuda, Y.; Tomiyama, T.; Ohashi, A.; Wada, S.; Kanai, N.; Satoh, Y.; Ido, K. und Sugano, K. (2001): Transpapillary intraductal US prior to biliary drainage in the assessment of longitudinal spread of extrahepatic bile duct carcinoma, Gastrointest Endosc (53) [3], Seite 300-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11231387

[70] Menzel, J.; Poremba, C.; Dietl, K. H. und Domschke, W. (2000): Preoperative diagnosis of bile duct strictures--comparison of intraductal ultrasonography with conventional endosonography, Scand J Gastroenterol (35) [1], Seite 77-82. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10672839

[71] Menzel, J. und Domschke, W. (2000): Gastrointestinal miniprobe sonography: the current status, Am J Gastroenterol (95) [3], Seite 605-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10710047

[72] Fritscher-Ravens, A.; Broering, D. C.; Sriram, P. V.; Topalidis, T.; Jaeckle, S.; Thonke, F. und Soehendra, N. (2000): EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case series, Gastrointest Endosc (52) [4], Seite 534-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11023576

[73] Reske, S. N.; Grillenberger, K. G.; Glatting, G.; Port, M.; Hildebrandt, M.; Gansauge, F. und Beger, H. G. (1997): Overexpression of glucose transporter 1 and increased FDG uptake in pancreatic carcinoma, J Nucl Med (38) [9], Seite 1344-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9293784

[74] Kluge, R.; Schmidt, F.; Caca, K.; Barthel, H.; Hesse, S.; Georgi, P.; Seese, A.; Huster, D. und Berr, F. (2001): Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer, Hepatology (33) [5], Seite 1029-35. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11343227

[75] Miraldi, F.; Vesselle, H.; Faulhaber, P. F.; Adler, L. P. und Leisure, G. P. (1998): Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer, Clin Nucl Med (23) [1], Seite 3-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9442955

[76] Soehendra, N. und Reynders-Frederix, V. (1979): [Palliative biliary duct drainage. A new method for endoscopic introduction of a new drain], Dtsch Med Wochenschr (104) [6], Seite 206-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=84736

[77] Belghiti, J.; Hiramatsu, K.; Benoist, S.; Massault, P.; Sauvanet, A. und Farges, O. (2000): Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection, J Am Coll Surg (191) [1], Seite 38-46. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10898182

[78] Speer, A. G.; Cotton, P. B.; Russell, R. C.; Mason, R. R.; Hatfield, A. R.; Leung, J. W.; MacRae, K. D.; Houghton, J. und Lennon, C. A. (1987): Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice, Lancet (2) [8550], Seite 57-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2439854

[79] Doctor, N.; Dick, R.; Rai, R.; Dafnios, N.; Salamat, A.; Whiteway, H.; Dooley, J. und Davidson, B. R. (1999): Results of percutaneous plastic stents for malignant distal biliary obstruction following failed endoscopic stent insertion and comparison with current literature on expandable metallic stents, Eur J Gastroenterol Hepatol (11) [7], Seite 775-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10445799

[80] Pahernik, S. A.; Dellian, M.; Berr, F.; Tannapfel, A.; Wittekind, C. und Goetz, A. E. (1998): Distribution and pharmacokinetics of Photofrin in human bile duct cancer, J Photochem Photobiol B (47) [1], Seite 58-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10052154

[81] Wiedmann, M.; Caca, K.; Berr, F.; Schiefke, I.; Tannapfel, A.; Wittekind, C.; Mossner, J.; Hauss, J. und Witzigmann, H. (2003): Neoadjuvant photodynamic therapy as a new approach to treating hilar cholangiocarcinoma: a phase II pilot study, Cancer (97) [11], Seite 2783-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12767091

[82] Berr, F.; Tannapfel, A.; Lamesch, P.; Pahernik, S.; Wiedmann, M.; Halm, U.; Goetz, A. E.; Mossner, J. und Hauss, J. (2000): Neoadjuvant photodynamic therapy before curative resection of proximal bile duct carcinoma, J Hepatol (32) [2], Seite 352-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10707878

[83] Ortner, M. E.; Caca, K.; Berr, F.; Liebetruth, J.; Mansmann, U.; Huster, D.; Voderholzer, W.; Schachschal, G.; Mossner, J. und Lochs, H. (2003): Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study, Gastroenterology (125) [5], Seite 1355-63. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14598251

[84] Berr, F.; Wiedmann, M.; Tannapfel, A.; Halm, U.; Kohlhaw, K. R.; Schmidt, F.; Wittekind, C.; Hauss, J. und Mossner, J. (2000): Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival, Hepatology (31) [2], Seite 291-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10655248

[85] Oertel, M.; Schastak, S. I.; Tannapfel, A.; Hermann, R.; Sack, U.; Mossner, J. und Berr, F. (2003): Novel bacteriochlorine for high tissue-penetration: photodynamic properties in human biliary tract cancer cells in vitro and in a mouse tumour model, J Photochem Photobiol B (71) [1-3], Seite 1-10. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14705633

[86] Rumalla, A.; Baron, T. H.; Wang, K. K.; Gores, G. J.; Stadheim, L. M. und de Groen, P. C. (2001): Endoscopic application of photodynamic therapy for cholangiocarcinoma, Gastrointest Endosc (53) [4], Seite 500-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11275896

[87] Ortner, M. (2001): Photodynamic therapy in the biliary tract, Curr Gastroenterol Rep (3) [2], Seite 154-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11276384

[88] Becker, T.; Lehner, F.; Bektas, H.; Meyer, A.; Luck, R.; Nashan, B. und Klempnauer, J. (2003): [Surgical Treatment for Hilar Cholangiocarcinoma (Klatskin-tumor)], Zentralbl Chir (128) [11], Seite 928-35. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14669113

[89] Shimada, H.; Endo, I.; Fujii, Y.; Kunihiro, O.; Tanaka, K.; Misuta, K. und Togo, S. (2002): Procedure of extended hilar bile duct resection and its application for hilar cholangiocarcinoma, Hepatogastroenterology (49) [44], Seite 300-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11995438

[90] Capussotti, L.; Muratore, A.; Polastri, R.; Ferrero, A. und Massucco, P. (2002): Liver resection for hilar cholangiocarcinoma: in-hospital mortality and longterm survival, J Am Coll Surg (195) [5], Seite 641-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12437251

[91] Jonas, S.; Steinmuller, T. und Neuhaus, P. (2001): [Surgical therapy of liver hilus tumors], Chirurg (72) [7], Seite 775-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11490755

[92] Neuhaus, P.; Jonas, S.; Settmacher, U.; Thelen, A.; Benckert, C.; Lopez-Hanninen, E. und Hintze, R. E. (2003): Surgical management of proximal bile duct cancer: extended right lobe resection increases resectability and radicality, Langenbecks Arch Surg (388) [3], Seite 194-200. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12819970

[93] Neuhaus, P.; Jonas, S.; Bechstein, W. O.; Lohmann, R.; Radke, C.; Kling, N.; Wex, C.; Lobeck, H. und Hintze, R. (1999): Extended resections for hilar cholangiocarcinoma, Ann Surg (230) [6], Seite 808-18; discussion 819. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10615936

[94] Childs, T. und Hart, M. (1993): Aggressive surgical therapy for Klatskin tumors, Am J Surg (165) [5], Seite 554-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7683844

[95] Abouna, G. M.; Preshaw, R. M.; Silva, J. L.; Hollingsworth, W. J.; Hershfield, N. B.; Novak, W.; Shaw, D. T. und Vetters, J. M. (1976): Liver transplantation in a patient with cholangiocarcinoma and ulcerative colitis, Can Med Assoc J (115) [7], Seite 615-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=184908

[96] Robles, R.; Figueras, J.; Turrion, V. S.; Margarit, C.; Moya, A.; Varo, E.; Calleja, J.; Valdivieso, A.; Garcia-Valdelcasas, J. C.; Lopez, P.; Gomez, M.; de Vicente, E.; Loinaz, C.; Santoyo, J.; Casanova, D.; Bernardos, A.; Fernandez, J. A.; Marin, C.; Ramirez, P.; Bueno, F. S.; Jaurrieta, E. und Parrilla, P. (2003): Liver transplantation for hilar cholangiocarcinoma: Spanish experience, Transplant Proc (35) [5], Seite 1821-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12962808

[97] Pascher, A.; Jonas, S. und Neuhaus, P. (2003): Intrahepatic cholangiocarcinoma: indication for transplantation, J Hepatobiliary Pancreat Surg (10) [4], Seite 282-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14598146

[98] Hassoun, Z.; Gores, G. J. und Rosen, C. B. (2002): Preliminary experience with liver transplantation in selected patients with unresectable hilar cholangiocarcinoma, Surg Oncol Clin N Am (11) [4], Seite 909-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12607579

[99] Sudan, D.; DeRoover, A.; Chinnakotla, S.; Fox, I.; Shaw, B., Jr.; McCashland, T.; Sorrell, M.; Tempero, M. und Langnas, A. (2002): Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma, Am J Transplant (2) [8], Seite 774-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12243499

[100] Kadry, Z.; Mullhaupt, B.; Renner, E. L.; Bauerfeind, P.; Schanz, U.; Pestalozzi, B. C.; Studer, G.; Zinkernagel, R. und Clavien, P. A. (2003): Living donor liver transplantation and tolerance: a potential strategy in cholangiocarcinoma, Transplantation (76) [6], Seite 1003-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14508370

[101] Price, P. (2001): Cholangiocarcinoma and the role of radiation and chemotherapy, Hepatogastroenterology (48) [37], Seite 51-2. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11268997

[102] Patt, Y. Z.; Hassan, M. M.; Lozano, R. D.; Waugh, K. A.; Hoque, A. M.; Frome, A. I.; Lahoti, S.; Ellis, L.; Vauthey, J. N.; Curley, S. A.; Schnirer, II und Raijman, I. (2001): Phase II trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer, Clin Cancer Res (7) [11], Seite 3375-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11705850

[103] Tsavaris, N.; Kosmas, C.; Gouveris, P.; Gennatas, K.; Polyzos, A.; Mouratidou, D.; Tsipras, H.; Margaris, H.; Papastratis, G.; Tzima, E.; Papadoniou, N.; Karatzas, G. und Papalambros, E. (2004): Weekly gemcitabine for the treatment of biliary tract and gallbladder cancer, Invest New Drugs (22) [2], Seite 193-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=14739669

[104] Chen, J. S.; Lin, Y. C.; Jan, Y. Y. und Liau, C. T. (2001): Mitomycin C with weekly 24-h infusion of high-dose 5-fluorouracil and leucovorin in patients with biliary tract and periampullar carcinomas, Anticancer Drugs (12) [4], Seite 339-43. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11335790

[105] Nakajima, T.; Takayama, T.; Miyanishi, K.; Nobuoka, A.; Hayashi, T.; Abe, T.; Kato, J.; Sakon, K.; Naniwa, Y.; Tanabe, H. und Niitsu, Y. (2003): Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-pi-specific inhibitor O1-hexadecyl-gamma-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester, J Pharmacol Exp Ther (306) [3], Seite 861-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12805482

[106] Vickers, S. M.; Jhala, N. C.; Ahn, E. Y.; McDonald, J. M.; Pan, G. und Bland, K. I. (2002): Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma), Ann Surg (235) [6], Seite 872-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12035045

[107] Gerhards, M. F.; van Gulik, T. M.; Gonzalez Gonzalez, D.; Rauws, E. A. und Gouma, D. J. (2003): Results of postoperative radiotherapy for resectable hilar cholangiocarcinoma, World J Surg (27) [2], Seite 173-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12616432

[108] Todoroki, T.; Ohara, K.; Kawamoto, T.; Koike, N.; Yoshida, S.; Kashiwagi, H.; Otsuka, M. und Fukao, K. (2000): Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma, Int J Radiat Oncol Biol Phys (46) [3], Seite 581-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10701737

[109] Flickinger, J. C.; Epstein, A. H.; Iwatsuki, S.; Carr, B. I. und Starzl, T. E. (1991): Radiation therapy for primary carcinoma of the extrahepatic biliary system. An analysis of 63 cases, Cancer (68) [2], Seite 289-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2070327

[110] Kurisu, K.; Hishikawa, Y.; Miura, T.; Kanno, H. und Okamoto, E. (1991): Radiotherapy of postoperative residual tumor of bile duct carcinoma, Radiat Med (9) [2], Seite 82-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1658858

[111] Mahe, M.; Romestaing, P.; Talon, B.; Ardiet, J. M.; Salerno, N.; Sentenac, I. und Gerard, J. P. (1991): Radiation therapy in extrahepatic bile duct carcinoma, Radiother Oncol (21) [2], Seite 121-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1866463

[112] Minsky, B.; Botet, J.; Gerdes, H. und Lightdale, C. (1992): Ultrasound directed extrahepatic bile duct intraluminal brachytherapy, Int J Radiat Oncol Biol Phys (23) [1], Seite 165-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1315312

[113] Noyes, R. D.; Weiss, S. M.; Krall, J. M.; Sause, W. T.; Owens, J. R.; Wolkov, H. B.; Lanciano, R.; Hanks, G. E. und Hoffmann, J. (1992): Surgical complications of intraoperative radiation therapy: the Radiation Therapy Oncology Group experience, J Surg Oncol (50) [4], Seite 209-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1640702

[114] Wolkov, H. B.; Graves, G. M.; Won, M.; Sause, W. T.; Byhardt, R. W. und Hanks, G. E. (1992): Intraoperative radiation therapy of extrahepatic biliary carcinoma: a report of RTOG-8506, Am J Clin Oncol (15) [4], Seite 323-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1514529

[115] Lillemoe, K. D. und Cameron, J. L. (2000): Surgery for hilar cholangiocarcinoma: the Johns Hopkins approach, J Hepatobiliary Pancreat Surg (7) [2], Seite 115-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10982602

[116] Schleicher, U. M.; Staatz, G.; Alzen, G. und Andreopoulos, D. (2002): Combined external beam and intraluminal radiotherapy for irresectable Klatskin tumors, Strahlenther Onkol (178) [12], Seite 682-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12491056

[117] Bruha, R.; Petrtyl, J.; Kubecova, M.; Marecek, Z.; Dufek, V.; Urbanek, P.; Kodadova, J. und Chodounsky, Z. (2001): Intraluminal brachytherapy and selfexpandable stents in nonresectable biliary malignancies--the question of long-term palliation, Hepatogastroenterology (48) [39], Seite 631-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11462891

[118] De Vreede, I.; Steers, J. L.; Burch, P. A.; Rosen, C. B.; Gunderson, L. L.; Haddock, M. G.; Burgart, L. und Gores, G. J. (2000): Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma, Liver Transpl (6) [3], Seite 309-16. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10827231

[119] Kasugai, T. (1975): Recent advances in the endoscopic retrograde cholangiopancreatography, Digestion (13) [1-2], Seite 76-99. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1104399

[120] Catarci, M.; Proposito, D.; Guadagni, S.; Tuscano, D.; Flati, G.; Zaraca, F.; Scaccia, M.; Scardamaglia, F. und Carboni, M. (1995): [History of reconstruction following total gastrectomy], Ann Ital Chir (66) [3], Seite 319-28. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8526300

[121] Forbes, A. und Cotton, P. B. (1984): ERCP and sphincterotomy after Billroth II gastrectomy, Gut (25) [9], Seite 971-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6469083

[122] Katon, R. M.; Bilbao, M. K.; Parent, J. A. und Smith, F. W. (1975): Endoscopic retrograde cholangiopancreatography in patients with gastrectomy and gastrojejunostomy (Billroth II), A case for the forward look, Gastrointest Endosc (21) [4], Seite 164-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1140534

[123] Thon, H. J.; Loffler, A.; Buess, G. und Gheorghiu, T. (1983): Is ERCP a reasonable diagnostic method for excluding pancreatic and hepatobiliary disease in patients with a Billroth II resection?, Endoscopy (15) [3], Seite 93-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=6872970

[124] Costamagna, G.; Mutignani, M.; Perri, V.; Gabrielli, A.; Locicero, P. und Crucitti, F. (1994): Diagnostic and therapeutic ERCP in patients with Billroth II gastrectomy, Acta Gastroenterol Belg (57) [2], Seite 155-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8053300

[125] Osnes, M.; Rosseland, A. R. und Aabakken, L. (1986): Endoscopic retrograde cholangiography and endoscopic papillotomy in patients with a previous Billroth-II resection, Gut (27) [10], Seite 1193-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3781333

[126] Saini, S. (1997): Imaging of the hepatobiliary tract, N Engl J Med (336) [26], Seite 1889-94. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9197218

[127] Semelka, R. C.; Kroeker, M. A.; Shoenut, J. P.; Kroeker, R.; Yaffe, C. S. und Micflikier, A. B. (1991): Pancreatic disease: prospective comparison of CT, ERCP, and 1.5-T MR imaging with dynamic gadolinium enhancement and fat suppression, Radiology (181) [3], Seite 785-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1947098

[128] Outwater, E. K. und Gordon, S. J. (1994): Imaging the pancreatic and biliary ducts with MR, Radiology (192) [1], Seite 19-21. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8208936

[129] Reinhold, C.; Guibaud, L.; Genin, G. und Bret, P. M. (1995): MR cholangiopancreatography: comparison between two-dimensional fast spin-echo and three-dimensional gradient-echo pulse sequences, J Magn Reson Imaging (5) [4], Seite 379-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7549198

[130] Soto, J. A.; Barish, M. A.; Yucel, E. K.; Siegenberg, D.; Ferrucci, J. T. und Chuttani, R. (1996): Magnetic resonance cholangiography: comparison with endoscopic retrograde cholangiopancreatography, Gastroenterology (110) [2], Seite 589-97. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8566608

[131] Hintze, R. E.; Adler, A.; Veltzke, W.; Abou-Rebyeh, H.; Hammerstingl, R.; Vogl, T. und Felix, R. (1997): Clinical significance of magnetic resonance cholangiopancreatography (MRCP) compared to endoscopic retrograde cholangiopancreatography (ERCP), Endoscopy (29) [3], Seite 182-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9201467

[132] Soto, J. A.; Barish, M. A.; Yucel, E. K.; Clarke, P.; Siegenberg, D.; Chuttani, R. und Ferrucci, J. T. (1995): Pancreatic duct: MR cholangiopancreatography with a three-dimensional fast spin-echo technique, Radiology (196) [2], Seite 459-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7617861

[133] Bilbao, M. K.; Dotter, C. T.; Lee, T. G. und Katon, R. M. (1976): Complications of endoscopic retrograde cholangiopancreatography (ERCP). A study of 10,000 cases, Gastroenterology (70) [3], Seite 314-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1248697

[134] Ducreux, M.; Liguory, C.; Lefebvre, J. F.; Ink, O.; Choury, A.; Fritsch, J.; Bonnel, D.; Derhy, S. und Etienne, J. P. (1992): Management of malignant hilar biliary obstruction by endoscopy. Results and prognostic factors, Dig Dis Sci (37) [5], Seite 778-83. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1373361

[135] Liu, C. L.; Lo, C. M.; Lai, E. C. und Fan, S. T. (1998): Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors, Arch Surg (133) [3], Seite 293-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9517743

[136] Hintze, R. E.; Adler, A.; Veltzke, W. und Abou-Rebyeh, H. (1997): Endoscopic access to the papilla of Vater for endoscopic retrograde cholangiopancreatography in patients with billroth II or Roux-en-Y gastrojejunostomy, Endoscopy (29) [2], Seite 69-73. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9101141

[137] Jonas, S.; Vogl, T. J.; Schwarz, W. und Neuhaus, P. (1998): [Differential diagnosis and therapy of benign liver tumors], Ther Umsch (55) [2], Seite 120-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9545855

[138] Ortner, M. A.; Liebetruth, J.; Schreiber, S.; Hanft, M.; Wruck, U.; Fusco, V.; Muller, J. M.; Hortnagl, H. und Lochs, H. (1998): Photodynamic therapy of nonresectable cholangiocarcinoma, Gastroenterology (114) [3], Seite 536-42. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9496944

[139] Earnshaw, J. J.; Hayter, J. P.; Teasdale, C. und Beckly, D. E. (1992): Should endoscopic stenting be the initial treatment of malignant biliary obstruction?, Ann R Coll Surg Engl (74) [5], Seite 338-41. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1384416

[140] Gandini, G.; Zanon, E.; Righi, D.; Fonio, P.; Ferrari, A. und Recchia, S. (1990): [Percutaneous transhepatic sphincterotomy], Radiol Med (Torino) (80) [6], Seite 893-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2281174

[141] Zanon, E.; Righi, D.; Maisano, U.; Regge, D.; Ferrari, A.; Recchia, S. und Gandini, G. (1991): Percutaneous transhepatic sphincterotomy--a report on 3 cases, Endoscopy (23) [1], Seite 25-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2009833

[142] Cobourn, C.; Makowka, L.; Ho, C. S.; Taylor, B. und Langer, B. (1986): Percutaneous transhepatic sphincterotomy in the management of biliary tract disease, Gastrointest Radiol (11) [3], Seite 273-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3743950

[143] Ricci, E.; Bertoni, G.; Conigliaro, R.; Contini, S.; Mortilla, M. G. und Bedogni, G. (1989): Endoscopic sphincterotomy in Billroth II patients: an improved method using a diathermic needle as sphincterotome and a nasobiliary drain as guide, Gastrointest Endosc (35) [1], Seite 47-50. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2920885

[144] van Buuren, H. R.; Boender, J.; Nix, G. A. und van Blankenstein, M. (1995): Needle-knife sphincterotomy guided by a biliary endoprosthesis in Billroth II gastrectomy patients, Endoscopy (27) [3], Seite 229-32. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7664700

[145] Wurbs, D.; Dammermann, R.; Ossenberg, F. W. und Classen, M. (1978): Descending sphincterotomy of the papilla of Vater through the T-drain under endoscopic view. Variants of endoscopic papillotomy (EPT), Endoscopy (10) [3], Seite 199-203. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=699888

[146] Hintze, R. E.; Veltzke, W.; Adler, A. und Abou-Rebyeh, H. (1997): Endoscopic sphincterotomy using an S-shaped sphincterotome in patients with a Billroth II or Roux-en-Y gastrojejunostomy, Endoscopy (29) [2], Seite 74-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9101142

[147] Safrany, L.; Neuhaus, B.; Portocarrero, G. und Krause, S. (1980): Endoscopic sphincterotomy in patients with Billroth II gastrectomy, Endoscopy (12) [1], Seite 16-22. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7353556

[148] Hintze, R. E.; Adler, A. und Veltzke, W. (1996): Outcome of mechanical lithotripsy of bile duct stones in an unselected series of 704 patients, Hepatogastroenterology (43) [9], Seite 473-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8799379

[149] Meyer zum Buschenfelde, K. H. (1990): [Therapeutic decision in gallstone disease from the internal medicine viewpoint], Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir, Seite 1225-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1983519

[150] Siegel, J. H.; Ben-Zvi, J. S. und Pullano, W. E. (1990): Mechanical lithotripsy of common duct stones, Gastrointest Endosc (36) [4], Seite 351-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2210275

[151] Vargas, F. und Garnica, E. (1990): [Biliary lithiasis. Non-surgical treatment], G E N (44) [4], Seite 361-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2152278

[152] Barish, M. A.; Yucel, E. K.; Soto, J. A.; Chuttani, R. und Ferrucci, J. T. (1995): MR cholangiopancreatography: efficacy of three-dimensional turbo spin-echo technique, AJR Am J Roentgenol (165) [2], Seite 295-300. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7618543

[153] Soto, J. A.; Yucel, E. K.; Barish, M. A.; Chuttani, R. und Ferrucci, J. T. (1996): MR cholangiopancreatography after unsuccessful or incomplete ERCP, Radiology (199) [1], Seite 91-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8633178

[154] Raper, S. E.; Barker, M. E.; Jones, A. L. und Way, L. W. (1989): Anatomic correlates of bacterial cholangiovenous reflux, Surgery (105) [3], Seite 352-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2646743

[155] Figueras, J.; Llado-Garriga, L.; Lama, C.; Pujol-Rafols, J.; Navarro, M.; Martinez-Villacampa, M.; Dominguez, J.; Sancho, C.; Rafecas, A.; Fabregat, J.; Torras, J.; Ramos, E.; Xiol, X.; Baliellas, C.; Casanovas, T. und Jaurrieta, E. (1998): [Resection as elective treatment of hilar cholangiocarcinoma (Klatskin tumor)], Gastroenterol Hepatol (21) [5], Seite 218-23. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9644874

[156] Deviere, J.; Baize, M.; de Toeuf, J. und Cremer, M. (1988): Long-term follow-up of patients with hilar malignant stricture treated by endoscopic internal biliary drainage, Gastrointest Endosc (34) [2], Seite 95-101. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2835282

[157] Liguory, C.; Lefebvre, J. F.; Vitale, G.; Bonnel, D. und Cornud, F. (1991): [Endoscopic and transhepatic intubation of malignant bile duct strictures for postoperative jaundice], Ann Chir (45) [6], Seite 471-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1929162

[158] Prat, F.; Chapat, O.; Ducot, B.; Ponchon, T.; Pelletier, G.; Fritsch, J.; Choury, A. D. und Buffet, C. (1998): A randomized trial of endoscopic drainage methods for inoperable malignant strictures of the common bile duct, Gastrointest Endosc (47) [1], Seite 1-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9468416

[159] Peters, R. A.; Williams, S. G.; Lombard, M.; Karani, J. und Westaby, D. (1997): The management of high-grade hilar strictures by endoscopic insertion of self-expanding metal endoprostheses, Endoscopy (29) [1], Seite 10-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9083730

[160] Cremer, M.; Deviere, J.; Sugai, B. und Baize, M. (1990): Expandable biliary metal stents for malignancies: endoscopic insertion and diathermic cleaning for tumor ingrowth, Gastrointest Endosc (36) [5], Seite 451-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1699836

[161] Hausegger, K. A.; Thurnher, S.; Bodendorfer, G.; Zollikofer, C. L.; Uggowitzer, M.; Kugler, C. und Lammer, J. (1998): Treatment of malignant biliary obstruction with polyurethane-covered Wallstents, AJR Am J Roentgenol (170) [2], Seite 403-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9456954

[162] Ghosh, S. und Palmer, K. R. (1994): Preventing biliary stent occlusion, Lancet (344) [8929], Seite 1087-8; author reply 1088-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7934468

[163] Adler, A.; Abou-Rebyeh, H.; Veltzke, W. ; Wiedenmann, B. und Hintze, R.E. (1999): Diagnostik und endoskopische Therapie beim zentralen Gallengangskarzinom, Onkologe (5(6)), Seite 490-498.

[164] Hiatt, J. R.; Quinones-Baldrich, W. J.; Ramming, K. P.; Brems, J. und Busuttil, R. W. (1987): Operations upon the biliary tract during transplantation of the liver, Surg Gynecol Obstet (165) [1], Seite 89-93. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3109048

[165] Lerut, J.; Gordon, R. D.; Iwatsuki, S.; Esquivel, C. O.; Todo, S.; Tzakis, A. und Starzl, T. E. (1987): Biliary tract complications in human orthotopic liver transplantation, Transplantation (43) [1], Seite 47-51. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=3541321

[166] Neuhaus, P.; Blumhardt, G.; Bechstein, W. O.; Steffen, R.; Platz, K. P. und Keck, H. (1994): Technique and results of biliary reconstruction using side-to-side choledochocholedochostomy in 300 orthotopic liver transplants, Ann Surg (219) [4], Seite 426-34. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8161269

[167] Ringe, B.; Oldhafer, K.; Bunzendahl, H.; Bechstein, W. O.; Kotzerke, J. und Pichlmayr, R. (1989): Analysis of biliary complications following orthotopic liver transplantation, Transplant Proc (21) [1 Pt 2], Seite 2472-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2652810

[168] Fisher, A. und Miller, C. H. (1995): Ischemic-type biliary strictures in liver allografts: the Achilles heel revisited?, Hepatology (21) [2], Seite 589-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7843733

[169] Hintze, R. E.; Abou-Rebyeh, H.; Adler, A.; Veltzke, W.; Langrehr, J.; Wiedenmann, B. und Neuhaus, P. (1999): [Endoscopic therapy of ischemia-type biliary lesions in patients following orthotopic liver transplantation], Z Gastroenterol (37) [1], Seite 13-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10091279

[170] Nakamura, K.; Murase, N.; Becich, M. J.; Furuya, T.; Todo, S.; Fung, J. J.; Starzl, T. E. und Demetris, A. J. (1993): Liver allograft rejection in sensitized recipients. Observations in a clinically relevant small animal model, Am J Pathol (142) [5], Seite 1383-91. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8494042

[171] Sanchez-Urdazpal, L.; Batts, K. P.; Gores, G. J.; Moore, S. B.; Sterioff, S.; Wiesner, R. H. und Krom, R. A. (1993): Increased bile duct complications in liver transplantation across the ABO barrier, Ann Surg (218) [2], Seite 152-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8342994

[172] Sebagh, M.; Farges, O.; Kalil, A.; Samuel, D.; Bismuth, H. und Reynes, M. (1995): Sclerosing cholangitis following human orthotopic liver transplantation, Am J Surg Pathol (19) [1], Seite 81-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7802140

[173] Hintze, R. E.; Adler, A.; Veltzke, W.; Abou-Rebyeh, H.; Felix, R. und Neuhaus, P. (1997): Endoscopic management of biliary complications after orthotopic liver transplantation, Hepatogastroenterology (44) [13], Seite 258-62. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9058155

[174] Li, S.; Stratta, R. J.; Langnas, A. N.; Wood, R. P.; Marujo, W. und Shaw, B. W., Jr. (1992): Diffuse biliary tract injury after orthotopic liver transplantation, Am J Surg (164) [5], Seite 536-40. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1443384

[175] Otto, G.; Roeren, T.; Golling, M.; Datsis, K.; Hofmann, W. J.; Herfarth, C. und Theilmann, L. (1995): [Ischemic type lesions of the bile ducts after liver transplantation: 2 years results], Zentralbl Chir (120) [6], Seite 450-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7543717

[176] Parc, Y.; Frileux, P.; Balladur, P.; Delva, E.; Hannoun, L. und Parc, R. (1997): Surgical strategy for the management of hilar bile duct cancer, Br J Surg (84) [12], Seite 1675-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9448613

[177] Wagner, H. E.; Ballmer, F. T. und Blumgart, L. H. (1987): [Hepatic portal tumor--today], Schweiz Med Wochenschr (117) [52], Seite 2104-12. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2829350

[178] Lillemoe, K. D. (1994): Current status of surgery for Klatskin tumors, Curr Opin Gen Surg, Seite 161-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7583956

[179] Thuluvath, P. J.; Rai, R.; Venbrux, A. C. und Yeo, C. J. (1997): Cholangiocarcinoma: a review, Gastroenterologist (5) [4], Seite 306-15. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9436006

[180] ten Hoopen-Neumann, H.; Gerhards, M. F.; van Gulik, T. M.; Bosma, A.; Verbeek, P. C. und Gouma, D. J. (1999): Occurrence of implantation metastases after resection of Klatskin tumors, Dig Surg (16) [3], Seite 209-13. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10436369

[181] Verbeek, P. C.; Van der Heyde, M. N.; Ramsoekh, T. und Bosma, A. (1990): Clinical significance of implantation metastases after surgical treatment of cholangiocarcinoma, Semin Liver Dis (10) [2], Seite 142-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2162566

[182] Soyer, P.; Pelage, J. P.; Dufresne, A. C.; Boudiaf, M. und Rymer, R. (1998): Abdominal wall metastatic tumor seeding along a percutaneous abscess drainage tract, AJR Am J Roentgenol (171) [6], Seite 1643-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9843305

[183] Roayaie, S.; Guarrera, J. V.; Ye, M. Q.; Thung, S. N.; Emre, S.; Fishbein, T. M.; Guy, S. R.; Sheiner, P. A.; Miller, C. M. und Schwartz, M. E. (1998): Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes, J Am Coll Surg (187) [4], Seite 365-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9783782

[184] Abou-Rebyeh, H.; Borgmann, V.; Nagel, R. und Al-Abadi, H. (2001): DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma, Cancer (92) [9], Seite 2280-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=11745282

[185] Rickaert, F.; Gelin, M.; van Gansbeke, D.; Lambilliotte, J. P.; Verhest, A.; Pasteels, J. L.; Kloppel, G. und Kiss, R. (1992): Computerized morphonuclear characteristics and DNA content of adenocarcinoma of the pancreas, chronic pancreatitis, and normal tissues: relationship with histopathologic grading, Hum Pathol (23) [11], Seite 1210-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1427750

[186] Ghadimi, B. M.; Sackett, D. L.; Difilippantonio, M. J.; Schrock, E.; Neumann, T.; Jauho, A.; Auer, G. und Ried, T. (2000): Centrosome amplification and instability occurs exclusively in aneuploid, but not in diploid colorectal cancer cell lines, and correlates with numerical chromosomal aberrations, Genes Chromosomes Cancer (27) [2], Seite 183-90. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10612807

[187] Heselmeyer, K.; Schrock, E.; du Manoir, S.; Blegen, H.; Shah, K.; Steinbeck, R.; Auer, G. und Ried, T. (1996): Gain of chromosome 3q defines the transition from severe dysplasia to invasive carcinoma of the uterine cervix, Proc Natl Acad Sci U S A (93) [1], Seite 479-84. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8552665

[188] Ried, T.; Knutzen, R.; Steinbeck, R.; Blegen, H.; Schrock, E.; Heselmeyer, K.; du Manoir, S. und Auer, G. (1996): Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors, Genes Chromosomes Cancer (15) [4], Seite 234-45. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8703849

[189] Deprez, C.; Vangansbeke, D.; Fastrez, R.; Pasteels, J. L.; Verhest, A. und Kiss, R. (1993): Nuclear DNA content, proliferation index, and nuclear size determination in normal and cirrhotic liver, and in benign and malignant primary and metastatic hepatic tumors, Am J Clin Pathol (99) [5], Seite 558-65. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8493949

[190] Ried, T.; Liyanage, M.; du Manoir, S.; Heselmeyer, K.; Auer, G.; Macville, M. und Schrock, E. (1997): Tumor cytogenetics revisited: comparative genomic hybridization and spectral karyotyping, J Mol Med (75) [11-12], Seite 801-14. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9428610

[191] Abou-Rebyeh, H.; Al-Abadi, H.; Jonas, S.; Rotter, I.; Bechstein, W. O. und Neuhaus, P. (2002): DNA analysis of cholangiocarcinoma cells: prognostic and clinical importance, Cancer Detect Prev (26) [4], Seite 313-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12430636

[192] Iwatsuki, S.; Todo, S.; Marsh, J. W.; Madariaga, J. R.; Lee, R. G.; Dvorchik, I.; Fung, J. J. und Starzl, T. E. (1998): Treatment of hilar cholangiocarcinoma (Klatskin tumors) with hepatic resection or transplantation, J Am Coll Surg (187) [4], Seite 358-64. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9783781

[193] El Rassi, Z. E.; Partensky, C.; Scoazec, J. Y.; Henry, L.; Lombard-Bohas, C. und Maddern, G. (1999): Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management, Eur J Surg Oncol (25) [4], Seite 375-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10419707

[194] Iachino, C.; Catsicojannis, N. und Dallera, F. (1998): Prognostic significance of tumor DNA content in carcinoma of the hepatic duct confluence, J Exp Clin Cancer Res (17) [4], Seite 425-30. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=10089062

[195] Farley, D. R.; Weaver, A. L. und Nagorney, D. M. (1995): "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention, Mayo Clin Proc (70) [5], Seite 425-9. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=7537346

[196] Verbeek, P. C.; Van Leeuwen, D. J.; Van Der Heyde, M. N. und Gonzalez Gonzalez, D. (1991): Does additive radiotherapy after hilar resection improve survival of cholangiocarcinoma? An analysis in sixty-four patients, Ann Chir (45) [4], Seite 350-4. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1648329

[197] Nimura, Y. (1993): Staging of biliary carcinoma: cholangiography and cholangioscopy, Endoscopy (25) [1], Seite 76-80. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8384103

[198] Sugiyama, M.; Atomi, Y.; Wada, N.; Kuroda, A. und Muto, T. (1996): Endoscopic transpapillary bile duct biopsy without sphincterotomy for diagnosing biliary strictures: a prospective comparative study with bile and brush cytology, Am J Gastroenterol (91) [3], Seite 465-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8633492

[199] Ponchon, T.; Gagnon, P.; Berger, F.; Labadie, M.; Liaras, A.; Chavaillon, A. und Bory, R. (1995): Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study, Gastrointest Endosc (42) [6], Seite 565-72. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=8674929

[200] Heyder, N. (1991): [Diagnosis of gastroenterologic diseases with sonography. Part 2: Gallbladder and bile ducts], Fortschr Med (109) [32], Seite 655-8. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=1769632

[201] Tio, T. L.; Cheng, J.; Wijers, O. B.; Sars, P. R. und Tytgat, G. N. (1991): Endosonographic TNM staging of extrahepatic bile duct cancer: comparison with pathological staging, Gastroenterology (100) [5 Pt 1], Seite 1351-61. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2013380

[202] Takayasu, K.; Ikeya, S.; Mukai, K.; Muramatsu, Y.; Makuuchi, M. und Hasegawa, H. (1990): CT of hilar cholangiocarcinoma: late contrast enhancement in six patients, AJR Am J Roentgenol (154) [6], Seite 1203-6. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=2159688

[203] Tham, T. C.; Carr-Locke, D. L.; Vandervoort, J.; Wong, R. C.; Lichtenstein, D. R.; Van Dam, J.; Ruymann, F.; Chow, S.; Bosco, J. J.; Qaseem, T.; Howell, D.; Pleskow, D.; Vannerman, W. und Libby, E. D. (1998): Management of occluded biliary Wallstents, Gut (42) [5], Seite 703-7. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9659168

[204] Hintze, R. E.; Adler, A.; Veltzke, W.; Ramani, N. V. und Abou-Rebyeh, H. (1997): Management of traction wire fracture complicating mechanical basket lithotripsy, Endoscopy (29) [9], Seite 883-5. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=9476774

[205] Abou-Rebyeh, H.; Veltzke-Schlieker, W.; Radke, C.; Steinmuller, T.; Wiedenmann, B. und Hintze, R. E. (2003): Complete bile duct sequestration after liver transplantation, caused by ischemic-type biliary lesions, Endoscopy (35) [7], Seite 616-20. http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=12822100